C
Channel Medsystems
Channel Medsystems - bringing innovation to the delivery of women’s healthcare
About Channel Medsystems
Cerene is a medical technology company specializing in innovative treatments for heavy menstrual bleeding. The company's flagship product is a cryotherapy device designed to ablate the endometrial lining of the uterus in premenopausal women who have completed childbearing. This treatment is performed in the comfort of a doctor's office without the need for general anesthesia, making it a convenient and less invasive option for patients. Cerene primarily serves women suffering from heavy menstrual bleeding due to benign causes, aiming to improve their quality of life by offering a safe, effective, and cost-efficient solution. The company operates in the healthcare market, focusing on gynecological treatments. Cerene's business model involves selling its cryotherapy devices to healthcare providers, who then offer the treatment to patients. Revenue is generated through the sale of these devices and potentially through follow-up services and support. The company is committed to empowering women to take control of their health journeys by providing innovative and accessible medical technologies.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- San Francisco, United States
- Employees
- 30
- Open positions
- None listed
- Dealroom signal
- 57.2/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing, Marketplace & ecommerce
- Client focus
- b2c
- Links
- Website
Latest news
Press, funding announcements and product moves mentioning Channel Medsystems.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Aug 2026 | $30M | $120M | InnovaHealth Partners | ↗ |
| SERIES C✓Equity / VC | Aug 2017 | $14M | $56M | Longwood Fund · Third Point Ventures · Boston Scientific · InCube Ventures | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Channel Medsystems is 3.7K monthly website visits, up 146.7% over the last three months. Channel Medsystems's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
- PNPneumRx
VentureHealth
Boston Scientific
InCube Ventures- APAperture Venture Partners
Series B and later4 investors entered at this stage
Longwood Fund
Third Point Ventures
Scientific Health Development Partners
InnovaHealth Partners
Other known investors2 additional known investors
Aperture Ventures Partners
Nucleate
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Channel Medsystems on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Channel Medsystems’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.